These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35346006)

  • 1. Inorganic-organic Synergy in Nano-hybrids Makes a New Class of Drug with Targeted Delivery: Glutamate Functionalization of Iron Nanoparticles for Potential Bone Marrow Delivery and X-ray Dynamic Therapy.
    Ghosh R; Mondal S; Mukherjee D; Adhikari A; Bhattacharyya M; Pal SK
    Curr Drug Deliv; 2022; 19(10):991-1000. PubMed ID: 35346006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles.
    Haque ST; Chowdhury EH
    Curr Drug Deliv; 2018; 15(4):485-496. PubMed ID: 29165073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and mechanism associated with drug conjugated inorganic nanoparticles.
    Bharti S; Kaur G; Jain S; Gupta S; Tripathi SK
    J Drug Target; 2019 Sep; 27(8):813-829. PubMed ID: 30601068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
    Taneja P; Sharma S; Sinha VB; Yadav AK
    Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-delivery nanoparticles for bone-tissue and dental applications.
    Higino T; França R
    Biomed Phys Eng Express; 2022 May; 8(4):. PubMed ID: 35439740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
    Zhang S; Sun J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.
    Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ
    Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The smart targeting of nanoparticles.
    Friedman AD; Claypool SE; Liu R
    Curr Pharm Des; 2013; 19(35):6315-29. PubMed ID: 23470005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient targeted drug delivery through apotransferrin loaded nanoparticles.
    Krishna AD; Mandraju RK; Kishore G; Kondapi AK
    PLoS One; 2009 Oct; 4(10):e7240. PubMed ID: 19806207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into nanoparticle cellular uptake and intracellular targeting.
    Yameen B; Choi WI; Vilos C; Swami A; Shi J; Farokhzad OC
    J Control Release; 2014 Sep; 190():485-99. PubMed ID: 24984011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-guided nanomedicines for anticancer drug delivery.
    Alshaer W; Hillaireau H; Fattal E
    Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics.
    Uskoković V
    Adv Colloid Interface Sci; 2023 May; 315():102903. PubMed ID: 37084546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study.
    Mondal S; Ghosh R; Adhikari A; Pal U; Mukherjee D; Biswas P; Darbar S; Singh S; Bose S; Saha-Dasgupta T; Pal SK
    ChemMedChem; 2021 Dec; 16(24):3739-3749. PubMed ID: 34550644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC.
    Chen H; Deng J; Yao X; He Y; Li H; Jian Z; Tang Y; Zhang X; Zhang J; Dai H
    J Nanobiotechnology; 2021 Oct; 19(1):342. PubMed ID: 34702291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted cellular delivery of robust enzyme nanoparticles for the treatment of drug-induced hepatotoxicity and liver injury.
    Lee MS; Kim NW; Lee JE; Kim MG; Yin Y; Kim SY; Ko BS; Kim A; Lee JH; Lim SY; Lim DW; Kim SH; Park JW; Lim YT; Jeong JH
    Acta Biomater; 2018 Nov; 81():231-241. PubMed ID: 30240953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic Porous Nanoparticles for Drug Delivery in Antitumoral Therapy.
    Parra-Nieto J; Del Cid MAG; de Cárcer IA; Baeza A
    Biotechnol J; 2021 Feb; 16(2):e2000150. PubMed ID: 32476279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.